ChemoFilter
ChemoFilter is revolutionizing cancer care by reducing chemotherapy toxicity while increasing doses to fight tumors and improve survival.
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location United States
- Currency USD
- Founded March 2013
- Employees 3
Company Summary
Traditional chemotherapy is highly effective against cancers and cost-effective, but limited by toxicity. New targeted drugs can limit the toxicity caused by traditional low-cost chemotherapy; however, these therapies are costly and difficult to develop. ChemoFilter, the next paradigm in cancer treatment, will allow for the use of traditional chemotherapeutics in a targeted manner with less toxicity and higher doses to better fight cancer.
Team
-
Anand S. PatelCo-Founder & CEONIH T-32 Postdoc, PGY-4 UCSF Radiology Resident. Entrepreneur. Medical device, VC, and IP experience. Extensive medical research background. Past President of California Radiological Society, Residents Section. Lobby experience on Capitol Hill and healthcare reform interests. Univ of Penn Bioengineer. Harvard MD. Twitter @AnandPatelMD
-
Steven W. HettsCo-Founder & Chief Medical OfficerAssociate Prof of Radiology, UCSF. Co-director of UCSF IR Research Lab. Chief of Neuro-IR at SFGH & VA. Extensive experience as an interventional radiologist with clinical adoption, development of image guided interventions/devices, and animal studies. Harvard AB. Harvard MD. Stanford/UCSF trained physician.
-
Albert K. ChinCo-Founder & Chief Development Officer30+ yrs exclusively working in device development/startups in Silicon Valley. Pavilion Medical (Device Incubator). Co-founder Origin Medsystems, Inc., which became Guidant Cardiac Surgery. 177 patents. UCSF MD. Stanford MS Mech.E. MIT BS.
Advisors
-
Support from: Reed Smith; O'Melveny & Myers; Wilson, Sonsini; and Perkins Coie.LawyerUnconfirmed
William HettsAccountantUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.